Sjogren Syndrome
Article Sidebar
Main Article Content
Abstract
Article Details
References
Williamson J. keratoconjunctivitis sicca, histology of lacrimal gland. Br J Ophthalmol 1973; 57:852-8.
Karameris A et al. Detection of Epstein Barr viral genome by an in situ hybridization method in salivary gland biopsies from patients with secondary Sjogrenûs syndrome. Clin Exp rheumatol 1992; 10:327-32.
Pflugfelder DC et al. Amphification of Epstein Barr virus genomic sequences in blood cells, lacrimal glands, and tears from primary Sjogrenûs syndrome patients. Ophthalmology 1990; 97:976-84.
Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV. Sjogrenûs syndrome.Proposed criteria for classification. Arthritis Rheum 1986; 577-85.
Fox RI, Tornwall J, Michelsom P. Current issues in diagnosis and treatment of Sjogrenûs syndrome. Curr Opin Rheumatol 1999; 11:364-71.
Vitali C, Bombardieri S, Moutsopoulos HM, Coll J, Gerli R, Hatron PY, et al. Assessment of European classification criteria for Sjogrenûs syndrome in a series of clinically defined cases: results of prospective multicenter study. The European study Group on Diagnostic Criteria for Sjogrenûs Syndrome. Ann Rheum
dis 1996; 55:116-21.
Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria proposed by the American-European Consensus Group. Ann rheum Dis 2002; 61:554-8.
Fox RI, Saito I. Criteria for diagnosis of Sjogrenûs syndrome. Rheum Dis Clin North Am 1994; 20:391-407.
Reveille JD, Arnett FC. The immunogenetics of Sjogrenûs syndrome. Rheum Dis Clin North Am 1994; 18:539-50.
Barber LD, Pflugfelder SC, Tauber J, Foulks GN. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years. Ophthalmology 2005; 112(10): 1790-4.